Skip to content

Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool

Digital Collected Patient Reported Outcomes in a Diabetes Cohort

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04383041
Acronym
DePRO
Enrollment
32
Registered
2020-05-11
Start date
2020-07-02
Completion date
2021-01-27
Last updated
2021-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Diabetes Mellitus, Type 2

Brief summary

In this study researchers want to gain more information on patients who are treated with Metformin for their Type 2 Diabetes. Adult female and male patients with a prescription of a Metformin containing drug will be invited to the study in a public pharmacy after the decision for treatment with Metformin has been made by the treating physician. The pharmacist will provide interested participants access to a special phone App and participants are asked to complete via this phone App a questionnaire on their health situation with special focus on their Type 2 Diabetes. This includes questions on complications and self-care activities in relation to their diabetes, questions on quality of life and health history. There will be no extra visit to the treating doctor or a pharmacy. The study is aiming to have the questionnaire completed by 300 participants.

Interventions

OTHERNo intervention

Completing questionnaires via ePRO app from their own mobile devices

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult female or male patient * Valid prescription for a Metformin containing drug approved in Germany * Decision to initiate treatment with Metformin was made by the treating physician as part of the routine treatment practice * Signed informed consent

Exclusion criteria

\- Not applicable

Design outcomes

Primary

MeasureTime frameDescription
Summary of Diabetes Self-Care Activities for Diabetes and Kidney Disease (SDSCA) ScoreBaselineThe SDSCA measure is a brief self-report questionnaire of diabetes self-management. It assesses the number of days per week in which respondents engage in diabetes health-related behaviors in the areas of general diet, diabetes-specific diet, physical activity, blood-glucose testing, foot care, and smoking. Minimum score 0. Maximum score 77. Higher scores indicate better self care.

Secondary

MeasureTime frameDescription
Association between SDSCA score and demographic/ disease characteristicsBaselineAssociation of Summary of Diabetes Self-Care Activities for Diabetes and Kidney Disease (SDSCA) with demographic and disease characteristics
Acceptance of participationBaseline
Adherence to documentationBaseline
Health related Quality of Life-EuroQol five dimensions Questionnaire (EQ-5D)BaselineDescriptive system of health-related quality of life states consisting of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression).
DTSQ Participation rateBaselineDiabetes Treatment Satisfaction Questionnaire (DTSQ) Number of invited, participating and non-participating patients (reasons for non-acceptance of study participation)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026